glp-1 research Frontiers GLP-1 weight loss drugs leave
Description
Bianchi M, DOria V, Braghini MR, Petrini S, Manco M
Patients typically experience reductions in HbA1c (glycated haemoglobin) of approximately 1.01.5% (1116 mmol/mol) when added to existing therapy, with some agents achieving even greater reductions
Simultaneously, reduce high-fat and high-sugar foods, which can worsen loose stools
Available at: Nature
This action in your digestive system, added to your bodys natural response, is why the most common side effect with GLP-1 drugs is gastrointestinal upsettummy trouble
Ten Kulve, et al (2016)
